Celltech, Oxford GlycoSciences and the Bidding War That Never Was
By Business Review Editor
Pharma Deals Review: Vol 2003 Issue 36 (Table of Contents)
Published: 3 May-2003
DOI: 10.3833/pdr.v2003.i36.906 ISSN: 1756-7874
Section: General
Abstract
Celltech acquired Oxford GlycoSciences (OGS) by offering a price of 182 pence per share...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
Last Issue PDF
RSS